Person who experienced the adverse event (patient)
Event ID | CASEID | CASEVERSION | I F COD | EVENT DT | MFR DT | INIT FDA DT | FDA DT | REPT COD | AUTH NUM | MFR NUM | MFR SNDR | LIT REF | AGE | AGE COD | AGE GRP | GNDR COD | E SUB | WT | WT COD | REPT DT | TO MFR | OCCP COD | REPORTER COUNTRY | OCCR COUNTRY |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
105038273 | 10503827 | 3 | F | 2014 | 20160825 | 20141008 | 20160831 | PER | US-PFIZER INC-2014275802 | PFIZER | 18.00 | YR | F | Y | 63.00000 | KG | 20160831 | CN | US | US |
Drug(s) used by person
Event ID | CASEID | DRUG SEQ | ROLE COD | DRUGNAME | PROD AI | VAL VBM | ROUTE | DOSE VBM | CUM DOSE CHR | CUM DOSE UNIT | DECHAL | RECHAL | LOT NUM | EXP DT | NDA NUM | DOSE AMT | DOSE UNIT | DOSE FORM | DOSE FREQ |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
105038273 | 10503827 | 1 | PS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 150 MG, UNK | 21992 | 150 | MG | PROLONGED-RELEASE TABLET | |||||||
105038273 | 10503827 | 2 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 100 MG (50MG X 2 TABLETS), DAILY | 21992 | 100 | MG | PROLONGED-RELEASE TABLET | |||||||
105038273 | 10503827 | 3 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 100 MG, 1X/DAY | J30637 | 21992 | 100 | MG | PROLONGED-RELEASE TABLET | QD | |||||
105038273 | 10503827 | 4 | SS | PRISTIQ EXTENDED-RELEASE | DESVENLAFAXINE SUCCINATE | 1 | Oral | 50 MG, 2X/DAY | 21992 | 50 | MG | PROLONGED-RELEASE TABLET | BID | ||||||
105038273 | 10503827 | 5 | C | BACLOFEN. | BACLOFEN | 1 | Oral | 10 MG, 3X/DAY | 0 | 10 | MG | TABLET | TID | ||||||
105038273 | 10503827 | 6 | C | BACLOFEN. | BACLOFEN | 1 | 0 | TABLET | |||||||||||
105038273 | 10503827 | 7 | C | LUTERA | ETHINYL ESTRADIOLLEVONORGESTREL | 1 | Oral | 0.01 MG, DAILY | 0 | .01 | MG | TABLET | |||||||
105038273 | 10503827 | 8 | C | MIRTAZAPINE. | MIRTAZAPINE | 1 | Oral | 30 MG, 1X/DAY AT BEDTIME | 0 | 30 | MG | TABLET | QD | ||||||
105038273 | 10503827 | 9 | C | ZOFRAN | ONDANSETRON HYDROCHLORIDE | 1 | Oral | 4 MG, AS NEEDED | 0 | 4 | MG | TABLET | |||||||
105038273 | 10503827 | 10 | C | LANSOPRAZOLE. | LANSOPRAZOLE | 1 | Oral | 30 MG, 2X/DAY | 0 | 30 | MG | CAPSULE | BID | ||||||
105038273 | 10503827 | 11 | C | MECLIZINE | MECLIZINE HYDROCHLORIDE | 1 | Oral | 25 MG, AS NEEDED | 0 | 25 | MG | TABLET | |||||||
105038273 | 10503827 | 12 | C | DICYCLOMINE | DICYCLOMINE HYDROCHLORIDE | 1 | Oral | 10 MG, AS NEEDED | 0 | 10 | MG | CAPSULE |
Indications of drugs used
Event ID | CASEID | INDI DRUG SEQ | INDI PT |
---|---|---|---|
105038273 | 10503827 | 1 | Post-traumatic stress disorder |
105038273 | 10503827 | 2 | Panic attack |
105038273 | 10503827 | 5 | Gastrooesophageal reflux disease |
105038273 | 10503827 | 6 | Fibromyalgia |
105038273 | 10503827 | 7 | Contraception |
105038273 | 10503827 | 8 | Insomnia |
105038273 | 10503827 | 9 | Nausea |
105038273 | 10503827 | 10 | Gastrooesophageal reflux disease |
105038273 | 10503827 | 11 | Vertigo |
105038273 | 10503827 | 12 | Gastrooesophageal reflux disease |
Outcome of event
no results found |
Reactions reported
Event ID | CASEID | DRUG REC ACT | PT |
---|---|---|---|
105038273 | 10503827 | Abdominal pain | |
105038273 | 10503827 | Anger | |
105038273 | 10503827 | Drug ineffective for unapproved indication | |
105038273 | 10503827 | Dyspepsia | |
105038273 | 10503827 | Dysphagia | |
105038273 | 10503827 | Frustration tolerance decreased | |
105038273 | 10503827 | Medication residue present | |
105038273 | 10503827 | Mood altered | |
105038273 | 10503827 | Product quality issue | |
105038273 | 10503827 | Product use issue |
Reporting Sources (this data is often not reported and may therefore be missing here)
no results found |
Therapies reported
Event ID | CASEID | DSG DRUG SEQ | START DT | END DT | DUR | DUR COD |
---|---|---|---|---|---|---|
105038273 | 10503827 | 1 | 201110 | 0 | ||
105038273 | 10503827 | 3 | 2014 | 0 | ||
105038273 | 10503827 | 4 | 20160824 | 0 | ||
105038273 | 10503827 | 7 | 2014 | 0 | ||
105038273 | 10503827 | 11 | 2014 | 0 |